MSTN and hepatocellular carcinoma: The total population was divided into two groups (a low myostatin group and a high myostatin group) using a cutoff point of 4.97 ng/mL, which provided the maximum sum of the specificity and sensitivity in being able to predict the risk of HCC development within 5 years.